Foreign-Trade Zones Board Reviews Proposal From Patheon API for Pharmaceutical Production in Ohio
March 14, 2026
March 14, 2026
WASHINGTON, March 14 (TNSFR) -- The U.S. Department of Commerce Foreign-Trade Zones Board is reviewing a proposal from Florence, South Carolina-based Patheon API Inc., expanding production activities at its facility in Cincinnati, Ohio, within Subzone 46K.
Under the current proposal, the company intends to produce a duty-free agonist treatment drug designed for ulcerative colitis, identified as API Ono-6414HY. This production would utilize a specific foreign-status active pharmaceut . . .
Under the current proposal, the company intends to produce a duty-free agonist treatment drug designed for ulcerative colitis, identified as API Ono-6414HY. This production would utilize a specific foreign-status active pharmaceut . . .